Generex Biotechnology Corporation (Generex) is engaged in the research, development and commercialization of drug delivery systems and technologies. The company focuses on drug delivery system of large molecules in the areas of diabetes, pain management and cancers. It has developed a proprietary platform technology to deliver drugs into the human body through the oral cavity. The proprietary and proven advanced technology platform includes buccal delivery technology and immunomedicines for the administration of formulations of large molecule drugs to the oral cavity. It has licensing and distribution agreements with many big companies to sell its products worldwide. The company has its operations in the US, Canada, Dubai, South Africa, Republic of Latvia and Bermuda. Generex is headquartered in Toronto, Ontario, Canada

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days.

Generex Biotechnology Corporation SWOT Analysis report provides you a strategic analysis and detailed overview of the company’s businesses and operations.

In this report, our analysts reveal the company’s business strategy, strengths, weakness, opportunities and threats and detailed information such as :
- Key events associated with the company,
- Major products, services and brands of the company,
- Key competitors,
- Key executives, biographies and employment history,
- Personnel heading key departments and functions,
- Important locations and subsidiaries
- Financial analysis and ratios based on the annual financial statements published by the company including a 5 years history.
- Interim ratios for the last five interim periods

You get also in deepth information about Generex Biotechnology Corporation operations to identify potential customers, partners and suppliers. Generex Biotechnology Corporation business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.



Latest Company Developments:

Table Of Contents


I - Generex Biotechnology Corporation Company Profile

Key Information
Overview
Key Employees and biographies
Operational Heads
Main Products and Services
Historical Data
Company Mission Statement
Operations And Subsidiaries
Headquarter

II - Generex Biotechnology Corporation Company Analysis

Business Description
Company Vision and Strategy
SWOT Analysis
Strengths, Weaknesses, Opportunities, Threats
Competitive Landscape

III - Generex Biotechnology Corporation Financial Analysis and Performance Charts

Financial Ratios
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

D. Medical Industries Limited (DMED) - Financial and Strategic SWOT Analysis Review

D. Medical Industries Limited (DMED) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary D. Medical Industries Limited (D. Medical) is a medical device company. The company through its subsidiaries undertakes research and development, manufacture and sale of products for the treatment ...

Orient Pharma Co., Ltd. (4166) - Financial and Strategic SWOT Analysis Review

Orient Pharma Co., Ltd. (4166) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Orient PHARMA Co., Ltd. (Oripharm) is a pharmaceutical company. The company manufactures and distributes pharmaceuticals. Its drug delivery technologies include multi-stages controlled release ...

Plant Bioscience Limited - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Plant Bioscience Limited - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • November 2014
  • by Global Data

Summary Plant Bioscience Limited (PBL) is a technology company. The company provides IP management, patent advisory and technology transfer services to life science companies and investors. It also offers ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.